Azenta (AZTA) Cash from Investing Activities (2010 - 2026)
Azenta's (AZTA) quarterly Cash from Investing Activities came in at -$78.0 million in Q1 2026, up 43.77% year-on-year from -$54.2 million in Q1 2025, and down 312.06% on a QoQ basis from $36.8 million in Q4 2025.
Azenta (AZTA) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 17 years of Cash from Investing Activities data on file, last reported at -$78.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 43.77% year-over-year to -$78.0 million in Q1 2026; TTM through Mar 2026 was -$209.6 million, a 162.34% decrease from a year earlier, with the FY2025 full-year figure at -$90.5 million, down 140.25% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$78.0 million, down from $36.8 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for AZTA reached as high as $1.8 billion in Q1 2022 and fell as low as -$374.5 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged $125.5 million across 5 years, with a median of $57.3 million in 2022.
- On a YoY basis, Cash from Investing Activities climbed as much as 62692.23% in 2022 and fell as far as 2038.04% in 2022.
- Year by year, Cash from Investing Activities stood at $56.4 million in 2022, then jumped by 75.71% to $99.0 million in 2023, then dropped by 22.16% to $77.1 million in 2024, then slumped by 52.3% to $36.8 million in 2025, then sank by 312.06% to -$78.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$78.0 million in Q1 2026, $36.8 million in Q4 2025, and -$29.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Azenta | 1.28 Bn | 1.04 Bn | 125.74 Mn | -77.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.98 Mn |
| Mar 31, 2026 | -77.98 Mn |
| Dec 31, 2025 | 36.77 Mn |
| Dec 31, 2025 | 36.77 Mn |
| Jun 30, 2025 | -29.70 Mn |
| Jun 30, 2025 | -29.70 Mn |
| Mar 31, 2025 | -138.67 Mn |
| Mar 31, 2025 | -138.67 Mn |
| Dec 31, 2024 | 77.09 Mn |
| Dec 31, 2024 | 77.09 Mn |
| Sep 30, 2024 | 198.01 Mn |
| Sep 30, 2024 | 198.01 Mn |
| Jun 30, 2024 | 199.74 Mn |
| Jun 30, 2024 | 199.74 Mn |
| Mar 31, 2024 | -272.03 Mn |
| Mar 31, 2024 | -272.03 Mn |
| Dec 31, 2023 | 99.03 Mn |
| Dec 31, 2023 | 99.03 Mn |
| Sep 30, 2023 | 102.49 Mn |
| Sep 30, 2023 | 102.49 Mn |